Skip to main content Accessibility help


  • Don Husereau (a1), Michael Drummond (a2), Stavros Petrou (a3), Chris Carswell (a4), David Moher (a5), Dan Greenberg (a6), Federico Augustovski (a7), Andrew H Briggs (a8), Josephine Mauskopf (a9) and Elizabeth Loder (a10)...


Economic evaluations of health interventions pose a particular challenge for reporting. There is also a need to consolidate and update existing guidelines and promote their use in a user friendly manner. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement is an attempt to consolidate and update previous health economic evaluation guidelines efforts into one current, useful reporting guidance. The primary audiences for the CHEERS statement are researchers reporting economic evaluations and the editors and peer reviewers assessing them for publication.

The need for new reporting guidance was identified by a survey of medical editors. A list of possible items based on a systematic review was created. A two round, modified Delphi panel consisting of representatives from academia, clinical practice, industry, government, and the editorial community was conducted. Out of 44 candidate items, 24 items and accompanying recommendations were developed. The recommendations are contained in a user friendly, 24 item checklist. A copy of the statement, accompanying checklist, and this report can be found on the ISPOR Health Economic Evaluations Publication Guidelines Task Force website (

We hope CHEERS will lead to better reporting, and ultimately, better health decisions. To facilitate dissemination and uptake, the CHEERS statement is being co-published across 10 health economics and medical journals. We encourage other journals and groups, to endorse CHEERS. The author team plans to review the checklist for an update in five years.


Corresponding author

Correspondence to: D Husereau, 879 Winnington Ave, Ottawa, ON K2B 5C4,


Hide All
1.Drummond, MF, Sculpher, MJ, Torrance, G, O'Brien, J, Stoddart, GL. Methods for the economic evaluation of health care programmes. 3rd ed.Oxford University Press, 2005.
2.Drummond, MF, Schwartz, JS, Jönsson, B, Luce, BR, Neumann, PJ, Siebert, U, et al.Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care 2008;24:244–58.
3.Rennie, D, Luft, HS. Pharmacoeconomic analyses. JAMA 2000;283:2158–60.
4.Neumann, PJ, Stone, PW, Chapman, RH, Sandberg, EA, Bell, CM. The quality of reporting in published cost-utility analyses, 1976–1997. Ann Intern Med 2000;132:964.
5.Rosen, AB, Greenberg, D, Stone, PW, Olchanski, NV, Neumann, PJ. Quality of abstracts of papers reporting original cost-effectiveness analyses. Med Decis Making 2005;25:424–8.
6.Turner, L, Shamseer, L, Altman, DG, Schulz, KF, Moher, D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev 2012;1:60.
7.Drummond, MF. A reappraisal of economic evaluation of pharmaceuticals. Science or marketing? Pharmacoeconomics 1998;14:19.
8.McGhan, WF, Al, M, Doshi, JA, Kamae, I, Marx, SE, Rindress, D. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force report. Value Health 2009;12:1086–99.
9.Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology. A report on principles. Ann Intern Med 1995;123:6170.
10.Drummond, MF, Jefferson, TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996;313:275–83.
11.Gold, MR. Cost-effectiveness in health and medicine. Oxford University Press, 1996.
12.Siegel, JE, Weinstein, MC, Russell, LB, Gold, MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1339–41.
13.Nuijten, MJ, Pronk, MH, Brorens, MJ, Hekster, YA, Lockefeer, JH, de Smet, PA, et al.Reporting format for economic evaluation: Part II: Focus on modelling studies. Pharmacoeconomics 1998;14:259–68.
14.Vintzileos, AM, Beazoglou, T. Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics. Am J Obstet Gynecol 2004;191:1070–6.
15.Drummond, M, Manca, A, Sculpher, M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care 2005;21:165–71.
16.Ramsey, S, Willke, R, Briggs, A, Brown, R, Buxton, M, Chawla, A, et al.Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005;8:521–33.
17.Goetghebeur, MM, Wagner, M, Khoury, H, Levitt, RJ, Erickson, LJ, Rindress, D. Evidence and value: impact on decisionmaking—the EVIDEM framework and potential applications. BMC Health Serv Rev 2008;8:270.
18.Davis, JC, Robertson, MC, Comans, T, Scuffham, PA. Guidelines for conducting and reporting economic evaluation of fall prevention strategies. Osteoporos Int 2010;22:2449–59.
19.Petrou, S, Gray, A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ 2011;342:d1766.
20.Petrou, S, Gray, A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ 2011;342:d1548.
21.Husereau, D, Drummond, M, Petrou, S, Carswell, C, Moher, D, Greenberg, D, et al.Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluations Publication Guidelines Task Force. Value in Health (forthcoming).
22.Moher, D, Schulz, KF, Simera, I, Altman, DG. Guidance for developers of health research reporting guidelines. PLoS Med 2010;7:e1000217.
23.Moher, D, Weeks, L, Ocampo, M, et al. Describing reporting guidelines for health research: a systematic review. J Clin Epi 2011;64:718–42.
24.Campbell, SM, Hann, M, Roland, MO, Quayle, JA, Shekelle, PG. The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial. Med Care 1999;37:964–8.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed